InvestorsHub Logo
Followers 74
Posts 3606
Boards Moderated 0
Alias Born 03/23/2013

Re: bfost post# 166990

Friday, 12/14/2018 8:08:32 AM

Friday, December 14, 2018 8:08:32 AM

Post# of 426304
Bfost - I owned stock in EXAS. I agree, there are similarities to AMRN. Here is a more detailed chart of EXAS.



I think AMRN may follow a similar path to EXAS. Exas got USPSTF approval for it's cologuard product in July 2016, then dropped after a big pop, then went sideways for about 6-9 months before starting it's upward climb.



I totally agree.

I think patience will pay off in a big way with a similar chart.



Agree again... kind of. We find ourselves in a much different situation post reduce-it when it comes to volume trades. Dollar volume has gone up 532%. This minimizes slippage (bid-ask spread) and makes it very easy to dance in and out of a position if one were to decide to sides step the dips. It's not hard to spot the turning points,... the slope of the 50dEMA guides the way. With that in mind, "Patience" = less pay off and more painful loss along the way (notice how the binary gap filled - yikes).
Anyway, the 50% retrace is the line in the sand IMO. Based on the drug efficacy, we should all end up richer from a similar chart outcome and more, but there will be growing doubts during any painful retrace over the next few months.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News